Extrahepatic manifestations of HCV infection: facts and controversies.
about
Pseudohyponatremia in a patient with HIV and hepatitis C coinfectionExtrahepatic manifestations of chronic hepatitis C virus infectionEstablishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.Immunology of hepatitis B virus and hepatitis C virus infectionPlatelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.Mixed cryoglobulinemia: new concepts.Hepatitis C virus-related lymphoproliferative disorders: an overview.Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Coeliac disease and C virus-related chronic hepatitis: a non association.Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection.Hepatitis C virus biology.Management of chronic hepatitis C.Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cellsAssessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.New insights into HCV-related rheumatologic disorders: A review.Hepatitis C virus cryoglobulinemia and non-hodgkin lymphomaAutoimmune manifestations in viral hepatitis.The hepatitis C virus infection as a systemic disease.Hepatitis C virus infection and autoimmune diseases.Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.Hepatitis C virus and autoimmunity.Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.Lymphotropic hepatitis C virus has an interferon-resistant phenotype.Effect of hepatitis C virus infection on the right ventricular functions, pulmonary arterypressure and pulmonary vascular resistance.Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection?Is hepatitis C virus a risk factor for thyroid autoimmunity?Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus.Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life.Hepatitis C: the complications of immune dysfunction.Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.Sperm ultrastructure and meiotic segregation in a group of patients with chronic hepatitis B and C.
P2860
Q24654167-BB5B2CB0-EA8B-42B8-AB40-3819AF047BE2Q26767084-5605B1F8-1926-49B7-B653-AF0E8413999EQ27473088-787D7C61-D2AE-48B1-AEF9-225571C4846BQ29618957-DF40E1B9-9A8E-41C3-ABF7-BBC164EA8CC7Q33372989-75AC69E6-E4AF-4385-9861-BFFF7807E16BQ33901848-C60085C3-3022-4F80-8FB6-2210188E61EEQ34098553-82235536-8F5B-4D0F-BCAE-5EC8F890A3A9Q34294938-B56B112F-D6DE-411B-9A49-243923A082EFQ34420816-BECBF888-135D-4CCE-994F-417335B0095FQ35072192-EB25C498-2063-4E77-B4DD-CDEC76B0407EQ35091465-251E4F7F-8FB3-4382-9750-3895342178CAQ35522138-CF34261F-0F88-478C-971D-5D9C827A24FBQ35786326-6A10DA1B-7537-425C-A137-AC4E623E9C93Q37532286-EBAFA7ED-5C25-47AD-921D-D042B7776393Q37610871-2C2FE5A8-24FD-45D5-8586-ED7F89EDC4C2Q38003148-6725BDAB-C9B8-45AF-B062-1351D5519BFDQ38046450-68ECF483-CD64-4797-A760-95724C3009CAQ38052844-CB252739-7D8F-4F93-9E8B-B8B9B6937A80Q38057221-8189A692-BB0B-467E-B534-E9C2A7E45FB7Q38298448-80691153-343F-45CE-921B-619039B34829Q38497354-2D2ADDE8-934F-48B8-B805-E15AC8B484D9Q38914780-37E70E7A-BDB9-46E7-B690-47014659FC71Q39094502-170B3AAC-9249-4CAA-82EF-AD74F8D55B4CQ41734837-573B21AF-E9E9-4A56-835E-D39CAA352ED6Q42498228-4001A67A-8226-4D76-A278-162AA9669659Q42774333-99548994-6426-4685-B4BD-DCE8EA717E87Q42999433-0F8A53EF-F464-46F9-91D6-72E5026C5D04Q43000093-8294E4C3-DD18-471C-84A7-C0ADF86E31B4Q43032263-3012DB09-A7F0-411A-8828-D90FD914B598Q43035003-B103721D-9A5B-4ED3-B84B-47553E577776Q45415714-A9E8DF1A-045E-46D7-BE0C-54995E7BCA6BQ47580213-C4BA54E6-BD24-4D4C-B532-6BF3145DF8EEQ47745089-19976B1E-551F-4AD3-AC9D-8B38B523DAC5Q50550677-7DB8479D-0A3F-434D-B857-5290C5325480Q51886507-BF73CB37-0BEE-4E05-AE12-57D956BB144F
P2860
Extrahepatic manifestations of HCV infection: facts and controversies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Extrahepatic manifestations of HCV infection: facts and controversies.
@ast
Extrahepatic manifestations of HCV infection: facts and controversies.
@en
type
label
Extrahepatic manifestations of HCV infection: facts and controversies.
@ast
Extrahepatic manifestations of HCV infection: facts and controversies.
@en
prefLabel
Extrahepatic manifestations of HCV infection: facts and controversies.
@ast
Extrahepatic manifestations of HCV infection: facts and controversies.
@en
P1476
Extrahepatic manifestations of HCV infection: facts and controversies.
@en
P2093
P304
P356
10.1016/S0168-8278(99)80239-6
P577
1999-08-01T00:00:00Z